Abiopharma

New Form SC 14D9 - Y-mAbs Therapeutics, Inc. Filed: 2025-08-18 AccNo: 0001104659-25-079582 Size: 1 MB

New Form 8-K - PharmaCyte Biotech, Inc. Filed: 2025-08-18 AccNo: 0001683168-25-006274 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors

New Form 8-K - VEEVA SYSTEMS INC Filed: 2025-08-18 AccNo: 0001393052-25-000058 Size: 229 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month

New Form 6-K - RedHill Biopharma Ltd. Filed: 2025-08-18 AccNo: 0001178913-25-002958 Size: 483 KB

RedHill Biopharma - RedHill Received Talicia®Licensing Payments Totaling $1.1 Million

Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season

LivaNova Launches Essenz Perfusion System in China

Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial

New Form 8-K - SOLIGENIX, INC. Filed: 2025-08-18 AccNo: 0001558370-25-011625 Size: 224 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025